Skip to main content
Equibles

WELLINGTON MANAGEMENT GROUP LLP

Position in VRDN — Viridian Therapeutics, Inc.\DE

CIK 902219 Boston, MA
Back to VRDN Full portfolio

Position in VRDN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$57,468,007
-$2,748,505 QoQ
Shares Held
3,128,362
+1.6% QoQ
Ownership
2.76%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#12
of 215 holders
Holding Since
Mar 2021
17 quarters on record
Voting authority Sole 0% Shared 85% None 15%

Common Shares in VRDN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

WELLINGTON MANAGEMENT GROUP LLP holds $15,052,705,482 across 207 Biotechnology names. VRDN ranks #46 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,247,658 $1,613,209,155
2 ARGX
Argenx SE
 930,548 $863,334,513
3 REGN
Regeneron Pharmaceuticals, Inc.
 1,270,087 $791,950,042
4 RVMD
Revolution Medicines, Inc.
 3,843,415 $719,794,757
5 ALNY
Alnylam Pharmaceuticals, Inc.
 2,110,407 $635,295,816
6 IONS
Ionis Pharmaceuticals Inc
 7,651,415 $606,680,693
7 CYTK
Cytokinetics Inc
 6,931,770 $590,517,483
8 MDGL
Madrigal Pharmaceuticals, Inc.
 825,714 $443,367,129

All Filings in VRDN

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $57,468,007 3,128,362
2026-03-31 $60,216,512 3,078,554
2025-12-31 $61,350,307 1,971,411
2025-09-30 $24,224,237 1,122,532
2025-06-30 $3,782,189 270,543
2025-03-31 $3,358,810 249,170
2024-12-31 $4,303,355 224,484
2024-09-30 $5,368,703 235,987
2024-06-30 $3,695,410 284,044
2024-03-31 $4,216,913 240,829
2023-12-31 $4,183,871 192,097
2023-09-30 $3,308,040 215,648
2023-06-30 $4,098,992 172,299
2023-03-31 $3,164,633 124,396
2022-12-31 $3,519,892 120,503
2021-06-30 $10,581,862 578,560
2021-03-31 $9,667,737 578,560